Building bridges between medical science and business development
Our mission is to help biotechs in the early stages of drug development to deliver on their mission of helping patients with cancer.
We provide to preclinical projects our in-depth understanding of the medical conditions of use of the future drug. This understanding allows to optimize the trajectory towards the proof-of-concept with sound go-to-market strategies, and thus, to de-risk the drug development process.
Thus, we contribute to improve the performance of the early-phase development and design a more readable strategy towards the optimal target indication.